Anzeige
Mehr »
Dienstag, 21.04.2026 - Börsentäglich über 12.000 News
BREAKING: Pacifica liefert hochgradige Treffer - Phase II trifft genau ins Ziel
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Investing.com

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
14:18Stephens raises Darling Ingredients stock price target on margin outlook
14:18Stephens cuts EQT stock price target to $73 on updated forecast
14:18Argus reiterates Vulcan Materials stock rating on growth outlook
14:18State Street stock price target raised to $168 by Argus on guidance
14:06IBM launches AI-powered customer experience solutions with Adobe
14:06J&J launches AI-powered cardiac mapping module at HRS meeting
14:06KeyBanc raises Consolidated Edison stock price target on valuation
14:06KeyBanc raises Entergy stock price target on data center growth
14:06Oppenheimer cuts Passage Bio stock price target on regulatory setback
14:06KeyBanc raises Remitly stock price target on easing headwinds
14:06Needham reiterates Hold on Apple stock amid CEO transition
14:06KeyBanc cuts Robinhood stock price target on lower estimates
13:54Textron Aviation secures order for nine Cessna Citation Latitude jets
13:54CVS Group appoints Laura Hagan as non-executive director
13:54ImmunityBio's Anktiva launches commercially in Saudi Arabia
13:54Soluna adds Blockware as first client at Texas wind-powered site
13:54Capstone invites shareholder questions ahead of investor FAQ
13:54SolarEdge launches 197 kWh commercial battery in Europe, Asia
13:54SVM Machining secures aerospace supply deal with Turbo-Jet
13:54NRG Energy declares quarterly dividend of $0.475 per share
13:54Cross Country Healthcare names Chris Tyrell as CIO
13:54QCAD stablecoin launches trading on Kraken exchange
13:54Guggenheim reiterates Inflarx stock rating on AAV opportunity
13:54Lenz Therapeutics stock price target cut to $48 by H.C. Wainwright
13:54H.C. Wainwright raises Century Therapeutics price target on diabetes therapy potential